US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 9.650
  • -0.150-1.53%
Close Jul 22 16:00 ET
  • 9.650
  • 0.0000.00%
Post 16:20 ET
734.65MMarket Cap-4849P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Travere Therapeutic Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 6, 2024

Revenue(YoY)

41.37M

+33.95%
EPS(YoY)

-1.76

-38.58%
Analyst Rating

Buy

Jun 30, 2024

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 60.521M--
--2024/Q2-- / 52.651M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 60.521M--
--2024/Q2-- / 52.651M--
May 6, 20242024/Q141.374M / 43.616M--
Feb 15, 20242023/Q445.059M / 41.816M--
Nov 7, 20232023/Q337.095M / 56.450M--

Unlock Free Earnings Estimates

Travere Therapeutic Earnings Reports

  • Travere Therapeutic | 10-Q: Quarterly report

    May 6 16:51 ET

  • Travere Therapeutic | 10-K: Annual report

    Feb 20 08:13 ET

  • Travere Therapeutic: Q3 2023 Earnings Report

    Nov 7, 2023 17:14 ET

  • Travere Therapeutic | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 17:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      63.64%

    • Hold

      36.36%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg